Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma

By Xu Yuanlin  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1396-1404

Informa Healthcare

Access to resources Recommend Favorite

Radiotherapy After Chemotherapy for Metastatic Seminoma--a Diminishing Role

By MRC Testicular Tumour Working Party   Duchesne G.M.   Stenning S.P.   Aass N.   Mead G.M.   Fossa S.D.   Oliver R.T.D.   Horwich A.   Read G.   Roberts I.T.   Rustin G.   Cullen M.H.   Kaye S.B.   Harland S.J.   Cook P.A.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 829-835

Elsevier

Access to resources Recommend Favorite

Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease

By Sobol Urszula   Rodriguez Tulio   Smith Scott   Go Aileen   Vimr Ross   Parthasarathy Mala   Guo Rong   Stiff Patrick  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1281-1287

Informa Healthcare

Access to resources Recommend Favorite

Malignant Teratoma Undifferentiated (MTU) Metastasising Solely as Differentiated Teratoma: Implications for the Aetiology of Residual Differentiated Disease Following Successful Chemotherapy

By Kelly S.A.   Lampert I.   Jantet G.   Price P.M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2120-2121

Elsevier

Access to resources Recommend Favorite

Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma

By Avilés Agustin   Jesús Nambo M.   Neri Natividad   Talavera Alejandra   Castañeda Claudia   Murillo Edgar   Cleto Sergio   Huerta-Guzmán Judith  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 269-272

Humana Press, Inc

Access to resources Recommend Favorite